Cargando…
Intravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study
Pretreatment with antihistamines for the prevention of hypersensitivity infusion reactions is recommended for certain biologics and chemotherapies. Cetirizine is the first injectable second-generation antihistamine recently approved for acute urticaria. A randomized, exploratory phase 2 study evalua...
Autores principales: | Holmes, Jarrod P., Peguero, Julio A., Garland, R. Campbell, North, Janine, Young, Stacia, Brent, Lonnie D., Joseph-Ridge, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565502/ https://www.ncbi.nlm.nih.gov/pubmed/34555839 http://dx.doi.org/10.1097/NAN.0000000000000444 |
Ejemplares similares
-
Evaluation of the Predictive Validity of Thermography in Identifying Extravasation With Intravenous Chemotherapy Infusions
por: Matsui, Yuko, et al.
Publicado: (2017) -
Primary Intravenous Set Consumption Across 3 Branded Infusion Pumps
por: Hedlund, Nancy, et al.
Publicado: (2017) -
Safety Profile of HTX-019 Administered as an Intravenous Infusion in Patients With Cancer: A Retrospective Analysis
por: Calcanes, George, et al.
Publicado: (2019) -
Intravenous Smart Pumps During Actual Clinical Use: A Descriptive Comparison of Primary and Secondary Infusion Practices
por: Giuliano, Karen K., et al.
Publicado: (2021) -
A randomized double-blind feasibility study comparing cetirizine and diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions: the PREMED-F1 study
por: Beaucage-Charron, Johannie, et al.
Publicado: (2022)